MedPath

Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study)

Phase 1
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000002971
Lead Sponsor
Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

metastasis, inoperable cases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease-free survival
Secondary Outcome Measures
NameTimeMethod
Overall survival
© Copyright 2025. All Rights Reserved by MedPath